Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02161003
Recruitment Status : Unknown
Verified June 2014 by Sayed Bakry, Al-Azhar University.
Recruitment status was:  Recruiting
First Posted : June 11, 2014
Last Update Posted : June 11, 2014
Sponsor:
Collaborators:
Cairo University
Ain Shams University
Affiliated Hospital to Academy of Military Medical Sciences
Wake Forest University Health Sciences
Information provided by (Responsible Party):
Sayed Bakry, Al-Azhar University

Brief Summary:
The problem of the incontinence imposes considerable strain on the child and their parents. These patients suffer from a long-life handicap and they need support and follow-up. The cost associated with these diseases has clearly been illustrated to be a major component in the healthcare spending picture, may be adding hundreds of thousands of dollars to healthcare cost, as well as loss of productivity in the work force. Fecal incontinence treatment has been a difficult challenge for surgeons for several generations until now the current traditional surgical result is unsatisfactory. Mesenchymal Stem Cells injection may represent a new attractive treatment option for anal sphincter lesions. Moreover, experimental injury of muscle of anal sphincter in rats has been successfully treated with stem cells injections. In this study, the investigators will shed more light on the ability of Mesenchymal Stem Cells to induce myogenesis and regenerate anal Sphincter of patients with fecal incontinence. It will be very useful to many Egyptian patients.

Condition or disease Intervention/treatment Phase
Fecal Incontinence Procedure: Stem Cells Injection Technique Procedure: Stem Cell Isolation Phase 1 Phase 2

Detailed Description:
A stem cell is capable of forming various tissue under definite signals received from the body. Stem cell research in animals has been an ongoing program in the west with fruitful results. Current challenges with the use of stem cells in clinical practice will be solve the many unanswered queries. To study the potential therapeutic effects of local Mesenchymal Stem cell injection in children presenting with fecal incontinence (FI) after posterior sagittal ano-rectoplasty (PSARP) operation for high imperforate anus. Children whom suffering from FI after PSARP for high imperforate anus will included in this study. Autologous MSC from the upper posterior iliac crest bone marrow sample will be extracted from patients under general anesthesia, in a suitable clean operation room. Will be Cultured and injected into the external anal sphincter defect using direct pena stimulator or ultra sound guidance. Then followed up for 180 days post injection, to assess the ability of mesenchymal stem cells to induce myogenesis of the anal Sphincter of patients with FI after PSARP.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Therapeutic Effect of Stem Cells in Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty
Study Start Date : October 2013
Estimated Primary Completion Date : September 2016
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bowel Movement

Arm Intervention/treatment
Experimental: Stem Cells Isolation

Stem cell isolation technique and Stem Cells Injection Technique The method of isolation of MSC from bone marrow will be carried out using the Ficoll-Paque technique for the isolation of mononucleated cells followed by the separation of MSC by adherence to plastic. Finally, the cells will be resuspended and counted using a hemocytometer.

Mononucleated cells will be cultured and incubated at 37°C in an atmosphere of 95% relative humidity and 5% CO2.

Procedure: Stem Cells Injection Technique
Injection of MSCs for the treatment of anal sphincter insufficiency is a potential alternative therapy for imperforate anus patients who have undergone primary PSARP with post-operative FI. In this study a single dose of 1.2 ml MSC will be divided into 12 part of 0.1ml of MSC, doses will be injected into the anal sphincter all around in 12 injection sites according to the clock meridian under general anesthesia without giving muscle relaxant.

Procedure: Stem Cell Isolation
From the upper posterior iliac crest 10 ml bone marrow sample will be extracted from patients using a heparinized syringe, under general anesthesia, in a suitable clean operation room.




Primary Outcome Measures :
  1. Main outcome measures [ Time Frame: 24 Weeks ]
    Incontinence Score


Secondary Outcome Measures :
  1. Assessment of Clinical Parameters [ Time Frame: 24 Weeks ]

    This Including:

    Clinical Assessment. Continence score.


  2. Clinical Assessment [ Time Frame: 12 Weeks ]
    Maximum dry interval per day will be measured after injection at day 1, 30 and 90.

  3. Clinical Assessment [ Time Frame: 24 Weeks ]
    MRI pelvic floor muscles study will be done after 90 days post injection.

  4. Assessment of Urinary sphin Assessment of Urinary Sphincter (Electrophysiology Study) [ Time Frame: 48 Weeks ]
    EMG study will be done after 90, 180 days post injection.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Years to 12 Years   (Child)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Male Childern Ages: above 2 Years old.

Patient with FI. After PSARP repair of high imperforate anus.

Absence of parasitic and infective bacterial growth after Stool analysis and stool culture.

-

Exclusion Criteria:

Any degree of Spinal cord injury, systemic, neuronal paralysis or sacral agenesis.

Absence of muscle activity detected by EMG.

Ano-rectal disorders such as tumors, fissures, anal or rectal prolapse, and rectocele.

Positive stool culture resistant to preoperative oral antibiotic therapy.

Previous injection of bulking agents at the level of sphincter.

Immunocompromise patient.

Previous adverse reaction to anesthesia.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02161003


Contacts
Layout table for location contacts
Contact: Refaat Ibrahiem El-Badawy +201001567863

Locations
Layout table for location information
Egypt
Pediatric Surgery Outpatients Clinics - Al Hussien Hospital Recruiting
Nasr City, Cairo, Egypt
Contact: Contact: Abdel-Wahab El-Okby, MD    +201001478100      
Sub-Investigator: Refaat Ibrahiem El-Badawy, MD         
Sponsors and Collaborators
Al-Azhar University
Cairo University
Ain Shams University
Affiliated Hospital to Academy of Military Medical Sciences
Wake Forest University Health Sciences
Investigators
Layout table for investigator information
Principal Investigator: Abdel-Wahab El-Okby, MD Al-Azhar University
Study Chair: Naglaa Ali Gadallah, MD Ain Shams University
Study Director: Sayed Bakry, PhD Al-Azhar University
Study Chair: Refaat El-Badawy, MD Al-Azhar University
Study Chair: Hala Gabr, MD Cairo University
Study Chair: Wael Wael Abu El Khier, MD Military Academy
Study Chair: Anthony Atala, MD Director of the Wake Forest Institute for Regenerative Medicine
Study Chair: Mostafa Elbahrawy, MSc Al-Azhar University

Layout table for additonal information
Responsible Party: Sayed Bakry, Associate Professor - Consultant of Isolation and Culturing of Stem Cells, Al-Azhar University
ClinicalTrials.gov Identifier: NCT02161003     History of Changes
Other Study ID Numbers: Azhar52980070
Azhar52980070 ( Other Grant/Funding Number: Al Azhar University )
First Posted: June 11, 2014    Key Record Dates
Last Update Posted: June 11, 2014
Last Verified: June 2014
Keywords provided by Sayed Bakry, Al-Azhar University:
Fecal Incontinence
Posterior Sagittal Ano-rectoplasty
Mesenchymal Stem Cell
Additional relevant MeSH terms:
Layout table for MeSH terms
Fecal Incontinence
Rectal Diseases
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases